The GMS560 gene panel guides cancer patients to personalised treatment and participation in clinical studies
Genomic Medicine Sweden (GMS) has developed a broad gene panel for solid tumours that facilitates detailed diagnostics for current and next generation targeted therapies. The new gene panel will be implemented in routine healthcare during the autumn. As precision...
Successful implementation of precision medicine at a national level
In Sweden, the key to the successful implementation of precision medicine in healthcare has been the bottom-up approach where academia and healthcare have joined forces to build a national infrastructure. 42 authors from the Clinical Genomics platform at SciLifeLab...
Sequencing of 7,000 genomes in Swedish clinical practice in 2021 for better diagnosis and treatment
In 2021, analyzes were performed of 5,000 samples with whole genome sequencing and almost 2,000 samples with whole exome sequencing in clinical routine in Sweden. The majority of these analyzes were performed for the diagnosis of patients with rare diseases. In...
The legal room for sharing genetic data for the purpose of providing care for others is limited
There are currently no legal opportunities for the healthcare regions to, on a large scale, access the genetic data of patients in other regions for the purpose of providing better and more equal care for patients all across Sweden. This is shown in a new report by...